| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | Keiichi Fujiwara | Q92525856 |
| P2860 | cites work | Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. | Q50512108 |
| Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. | Q51301047 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer | Q85179739 | ||
| Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G | Q33335882 | ||
| Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study | Q33385242 | ||
| A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study | Q33393909 | ||
| Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer. | Q35886105 | ||
| Principles and practice of intraperitoneal chemotherapy for ovarian cancer | Q36732590 | ||
| Can carboplatin replace cisplatin for intraperitoneal use? | Q37108668 | ||
| Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal | Q46646219 | ||
| First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up | Q47621107 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 75-77 | |
| P577 | publication date | 2012-04-03 | |
| P1433 | published in | Journal of gynecologic oncology | Q26842232 |
| P1476 | title | Three ongoing intraperitoneal chemotherapy trials in ovarian cancer | |
| P478 | volume | 23 |
| Q86645764 | A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer |
| Q24187061 | Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer |
| Q37249312 | Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study. |
| Q39192789 | Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions |
| Q24186509 | Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer |
| Q36444374 | Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. |
| Q58563268 | Novel Surgical Strategies in the Treatment of Gynecological Malignancies |
| Q37489450 | Salvage intraperitoneal chemotherapy for relapsed type II endometrial cancer: A pilot case-control study |
Search more.